Clinical Trial Update: Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating AC2993 for glucose control and its safety/tolerability in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AC2993 (AC2993)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 2 | Status: COMPLETED